NYSE: BHVN - Biohaven Pharmaceutical Holding Company Ltd.

Price = Avg Price + (Avg Price * CAGR EPS% / 100)
EPS = Earning Per Share
CAGR EPS = CAGR 5 EPS
Key Rate — Nøkkelrente
Excess Key Rate — Ønsket overskridelse av styringsrenten
EPS = -5.73
CAGR EPS = 9.16%
Key Rate = 0.0458
Excess Key Rate = 2
Price = 38.87 + (38.87 * 9.16% / 100) = 42.43

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Discount Ebitda / (1 + WACC) ^ 5)
Discount Ebitda(5) = -0.3639
Ebitda Yield = -0.0324
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.0014
Debt = 0.0309
Market Cap = 1.32
Weight Debt = Market Cap / (Market Cap + Debt) = 1.32 / (1.32 + 0.0309) = 0.9771
Weight Cost Debt = 100% - 0.9771 = 0.0229
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 2.6
β = 1.6
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 2.6 + 1.6 * 5.94 + 0 = 0.1213
WACC = (0.0014 / 0.0309) * (100% - 0.9771) * (1 - 0.21) + 0.1213 + 0.9771 = 3.67
Terminal Value = Discount (-0.3639 * (1 + -0.0324) / (3.67 - -0.0324)) = -4.26
Company Value = ∑ (-0.3639 / (1 + 3.67) ^ 5) = -1.75
Price = (Terminal Value + Company Value) / Count shares = (-4.26 + -1.75) / 71200000 = -84.43

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield)
Company Value = ∑ (Discount FCF / (1 + WACC) ^ 5)
Discount FCF(5) = -0.3019
FCF Yield = -0.0204
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.0014
Debt = 0.0309
Market Cap = 1.32
Weight Debt = Market Cap / (Market Cap + Debt) = 1.32 / (1.32 + 0.0309) = 0.9771
Weight Cost Debt = 100% - 0.9771 = 0.0229
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 2.6
β = 1.6
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 2.6 + 1.6 * 5.94 + 0 = 0.1213
WACC = (0.0014 / 0.0309) * (100% - 0.9771) * (1 - 0.21) + 0.1213 + 0.9771 = 3.67
Terminal Value = Discount (-0.3019 * (1 + -0.0204) / (3.67 - -0.0204)) = -4.33
Company Value = ∑ (-0.3019 / (1 + 3.67) ^ 5) = -1.42
Price = (Terminal Value + Company Value) / Count shares = (-4.33 + -1.42) / 71200000 = -80.68